Antiangiogenic molecules from marine actinomycetes and the importance of using zebrafish model in cancer research
- PMID: 33319107
- PMCID: PMC7725737
- DOI: 10.1016/j.heliyon.2020.e05662
Antiangiogenic molecules from marine actinomycetes and the importance of using zebrafish model in cancer research
Abstract
Blood vessel sprouting from pre-existing vessels or angiogenesis plays a significant role in tumour progression. Development of novel biomolecules from marine natural sources has a promising role in drug discovery specifically in the area of antiangiogenic chemotherapeutics. Symbiotic actinomycetes from marine origin proved to be potent and valuable sources of antiangiogenic compounds. Zebrafish represent a well-established model for small molecular screening and employed to study tumour angiogenesis over the last decade. Use of zebrafish has increased in the laboratory due to its various advantages like rapid embryo development, optically transparent embryos, large clutch size of embryos and most importantly high genetic conservation comparable to humans. Zebrafish also shares similar physiopathology of tumour angiogenesis with humans and with these advantages, zebrafish has become a popular model in the past decade to study on angiogenesis related disorders like diabetic retinopathy and cancer. This review focuses on the importance of antiangiogenic compounds from marine actinomycetes and utility of zebrafish in cancer angiogenesis research.
Keywords: Actinomycetes; Angiogenesis; Bioactive molecules; Biomedical engineering; Biotechnology; Cancer research; Danio rerio; Developmental biology; Genetics; Molecular biology; Pharmaceutical science; Proteins; Toxicology; Transgenic model; Xenograft model.
© 2020 The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Zebrafish embryo intersegmental vessels: a tool for investigating sprouting angiogenesis.Methods Mol Biol. 2015;1214:173-84. doi: 10.1007/978-1-4939-1462-3_10. Methods Mol Biol. 2015. PMID: 25468604
-
Antiangiogenic cancer drug using the zebrafish model.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1846-53. doi: 10.1161/ATVBAHA.114.303221. Epub 2014 Jun 5. Arterioscler Thromb Vasc Biol. 2014. PMID: 24903092 Review.
-
Zebrafish embryo, a tool to study tumor angiogenesis.Int J Dev Biol. 2011;55(4-5):505-9. doi: 10.1387/ijdb.103238ct. Int J Dev Biol. 2011. PMID: 21858773 Review.
-
Significance of the zebrafish model in the discovery of bioactive molecules from nature.Biotechnol Lett. 2009 Feb;31(2):171-9. doi: 10.1007/s10529-008-9868-1. Epub 2008 Oct 19. Biotechnol Lett. 2009. PMID: 18931972 Review.
-
Mammalian tumor xenografts induce neovascularization in zebrafish embryos.Cancer Res. 2007 Apr 1;67(7):2927-31. doi: 10.1158/0008-5472.CAN-06-4268. Cancer Res. 2007. PMID: 17409396
Cited by
-
Application of Zebrafish as a Model for Anti-Cancer Activity Evaluation and Toxicity Testing of Natural Products.Pharmaceuticals (Basel). 2023 Jun 1;16(6):827. doi: 10.3390/ph16060827. Pharmaceuticals (Basel). 2023. PMID: 37375774 Free PMC article. Review.
-
Bioactive Microbial Metabolites in Cancer Therapeutics: Mining, Repurposing, and Their Molecular Targets.Curr Microbiol. 2022 Aug 24;79(10):300. doi: 10.1007/s00284-022-02990-7. Curr Microbiol. 2022. PMID: 36002695 Review.
-
Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review.Front Pharmacol. 2022 Jul 11;13:929161. doi: 10.3389/fphar.2022.929161. eCollection 2022. Front Pharmacol. 2022. PMID: 35899111 Free PMC article. Review.
-
Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from Serratia marcescens ATCC 27117.Molecules. 2022 Jun 9;27(12):3729. doi: 10.3390/molecules27123729. Molecules. 2022. PMID: 35744855 Free PMC article.
-
Volatile Organic Compounds from Bacillus aryabhattai MCCC 1K02966 with Multiple Modes against Meloidogyne incognita.Molecules. 2021 Dec 24;27(1):103. doi: 10.3390/molecules27010103. Molecules. 2021. PMID: 35011333 Free PMC article.
References
-
- Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995;1(1):27–31. - PubMed
-
- Risau W. Mechanisms of angiogenesis. Nature. 1997;386(6626):671–674. - PubMed
-
- Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature. 2005;438:967–974. - PubMed
-
- Siemann D.W., Chaplin D.J., Horsman M.R. Vascular-targeting therapies for treatment of malignant disease. Cancer. 2004;100:2491–2499. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous